Oncolytics Biotech:剩余33个Reo试验中心将于八月底前启动,以加速2026年下半年患者入组

美股速递
Jul 13

Oncolytics Biotech宣布,为加速推进2026年下半年的患者招募工作,其剩余的33个Reo试验中心计划于八月底前全部启动。这一举措旨在提升试验效率,加快相关临床研究的整体进程。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10